- Home
- MSN vs PHGE Comparison
MSN vs PHGE Comparison
Compare MSN & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSN
- PHGE
- Stock Information
- Founded
- MSN 1948
- PHGE 2015
- Country
- MSN United States
- PHGE Israel
- Employees
- MSN N/A
- PHGE N/A
- Industry
- MSN Consumer Electronics/Appliances
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- MSN Consumer Staples
- PHGE Health Care
- Exchange
- MSN Nasdaq
- PHGE Nasdaq
- Market Cap
- MSN 9.3M
- PHGE 10.4M
- IPO Year
- MSN 1994
- PHGE N/A
- Fundamental
- Price
- MSN $0.42
- PHGE $0.54
- Analyst Decision
- MSN
- PHGE Strong Buy
- Analyst Count
- MSN 0
- PHGE 1
- Target Price
- MSN N/A
- PHGE $15.00
- AVG Volume (30 Days)
- MSN 344.5K
- PHGE 12.5M
- Earning Date
- MSN 08-14-2025
- PHGE 08-13-2025
- Dividend Yield
- MSN N/A
- PHGE N/A
- EPS Growth
- MSN N/A
- PHGE N/A
- EPS
- MSN N/A
- PHGE N/A
- Revenue
- MSN $10,262,000.00
- PHGE N/A
- Revenue This Year
- MSN N/A
- PHGE N/A
- Revenue Next Year
- MSN N/A
- PHGE N/A
- P/E Ratio
- MSN N/A
- PHGE N/A
- Revenue Growth
- MSN 8.49
- PHGE N/A
- 52 Week Low
- MSN $0.28
- PHGE $0.34
- 52 Week High
- MSN $0.59
- PHGE $1.23
- Technical
- Relative Strength Index (RSI)
- MSN 45.38
- PHGE 52.66
- Support Level
- MSN $0.32
- PHGE $0.52
- Resistance Level
- MSN $0.44
- PHGE $0.56
- Average True Range (ATR)
- MSN 0.05
- PHGE 0.04
- MACD
- MSN -0.01
- PHGE -0.00
- Stochastic Oscillator
- MSN 34.78
- PHGE 48.25
About MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).